Jordan · Delayed Price · Currency is JOD Philadelphia Pharmaceuticals Company Company Description
Philadelphia Pharmaceuticals Company develops, manufactures, and markets human pharmaceutical products, cosmetics, and medical devices of various therapeutic categories in Jordan.
The company provides products for skin related disorders, including anti-lice and scabicides preparations, antiseptics and disinfectants, bleaching and hyperpigmentation disorders preparations, emollients and protectives, keratolytics/topical psoriasis treatment preparations, and skin healing agents, as well as agents for dermatitis; and topical acne preparation, anti-pruritic, anti-viral, plain antifungal and anti-infective, plain steroid, steroids with antifungal/anti-infective combination, and skin recoloring products.
It also offers products for women health, such as vaginal antifungals, alkalinizing and cleansing agents, antimicrobials, germicidal fungicidal, antiseptics and hemostatic, and vaginal progesterone; and products in the areas of alimentary, gastrointestinal system, anti-inflammatory, analgesic, antipyretic, dental-oropharyngeal, hair care, local anesthetics, and respiratory system, as well as supplements and health care-OTC products.
The company also exports its products in the Middle East and North Africa region. Philadelphia Pharmaceuticals Company was founded in 1993 and is headquartered in Amman, Jordan.
| Country | Jordan |
| Founded | 1993 |
| Industry | Pharmaceutical Preparations |
| Employees | 129 |
| CEO | Jamal Ishaq Abu Al Hawa |
Contact Details
Address: Azadi Complex Amman Jordan | |
| Phone | 962 6 4200507 |
| Website | philapharma.com |
Stock Details
| Ticker Symbol | PHIL |
| Exchange | Amman Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | JOD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jamal Ishaq Abu Al Hawa | Chief Executive Officer |
| Belal Abdujabbar Salameh | Chief Financial Officer |